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?Abstract? Objective To investigate the effect of human umbilical cord mesenchymal 
stem cells (hUC-MSCs) on proliferation of luminal B breast cancer cells and its underlying molecular 
mechanisms. Methods Human luminal B breast cancer cells BT474 were infected with GFP and 
luciferase co-expressing lentiviruses and then subjected for selection with Puromycin for 2 weeks. 
The expression of GFP and luciferase was detected by fluorescent microscopy and IVIS Kinetic 
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image system, respectively. The effect of coculture or treatment with conditioned medium of hUC-
MSCs on proliferation of BT474 was analyzed with MTS assay. Western blot was carried out to 
detect the effect of treatment with conditioned medium of hUC-MSCs on the activation of both Akt 
and MAPK signalings in BT474, as well as the expression of downstream cell cycle regulator Cyclin 
D1. Regular RT-PCR was applied to analyze the mRNAs expression of ligands such as NRG-1, 
NRG-2, IGF-I, IGF-II, and EGF in hUC-MSCs. The correlation between relative luciferase activity 
and cell number was analyzed with Excel software, while MTS assay data was statistically analyzed 
with SPSS 13.0 software. Results The co-expression of GFP and luciferase in BT474 via lentiviral 
expression system was visualized by fluorescent microscopy and IVIS Kinetic image system. The 
linear correlation between relative luciferase activity and cell number was determined by curve fitting 
analysis. Coculture or treatment with conditioned medium of hUC-MSC significantly promoted the 
proliferation of BT474, with survival rates being 148.06??P < 0.005?and 147.99??P < 0.001?
of control, respectively. In addition, treatment with conditioned medium of hUC-MSC was shown 
to induce activation of both Akt and MAPK signalings, which further upregulated the expression of 
Cyclin D1. Moreover, high mRNAs expression levels of both NRG-1 and EGF, as well as moderate 
mRNAs expression levels NRG-2, IGF-I, and IGF-II were showed by RT-PCR. Conclusion Our 
results here demonstrated that MSCs may promote the proliferation of luminal B breast cancer cells 
through paracrine of ligands such as NRG-1, which in turn results in the activation of both Akt and 
MAPK signalings and upregulation of the expression of Cyclin D1.
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